Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Waldenstrom Macroglobulinemia × Lenalidomide × Clear all

Phase

Status

Completed 7 Terminated 5 Withdrawn 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 44 Lymphoma, Large B-Cell, Diffuse 15 Lymphoma, Follicular 15 Lymphoma, B-Cell, Marginal Zone 12 Lymphoma 7 Recurrence 6 Neoplasms 6 Lymphoma, Non-Hodgkin 6 Lymphoma, Mantle-Cell 4 Lymphoma, B-Cell 4 Neoplasms, Plasma Cell 3 Neoplasm, Residual 2 Hematologic Neoplasms 2 Waldenstrom Macroglobulinemia 1 Smoldering Multiple Myeloma 1 Peripheral Nervous System Diseases 1 Paraproteinemias 1 Lymphoma, T-Cell, Peripheral 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Hairy Cell 1 Hodgkin Disease 1 Hematologic Diseases 1 Heart Failure 1 Dendritic Cell Sarcoma, Interdigitating 1 Corneal Diseases 1 Cardiotoxicity 1 Burkitt Lymphoma 1 Blood Protein Disorders 1 Amyloidosis 1

Interventions

Rituximab 7 zanubrutinib 6 venetoclax 5 Dexamethasone 4 pirtobrutinib 2 ibrutinib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 Biopsy 2 Bendamustine Hydrochloride 2 obinutuzumab 1 loncastuximab tesirine 1 Positron-Emission Tomography 1 Lenalidomide 1 Exercise 1 Diet 1 Calcium Dobesilate 1 CT-P10 1 Bortezomib 1 Blood Specimen Collection 1 ARQ531 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03697356 2023-10-06

Ballondor

Kosin University Gospel Hospital

Phase 2 Recruiting

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡